Vertex Pharmaceuticals Alternatives & Competitors
12 companies similar to Vertex Pharmaceuticals — The Science of Possibility
Companies similar to Vertex Pharmaceuticals
Tokyo, Japan
Jazz Pharmaceuticals
Identifying, developing and commercializing meaningful products that address unmet medical...
Dublin, Ireland
Merck & Co., Inc.
Merck develops and produces medicines, vaccines, biologic therapies and animal health prod...
Ultragenyx
Going Beyond Every Day
Novato, United States
Rival Readout
Competing with Vertex Pharmaceuticals? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Lumos Pharma
Transforming Lives with Rare Focus
Austin, United States
Code Biotherapeutics
Pioneering targeted delivery of precision genetic medicines
United States
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Waltham, United States
Nuvamid
A clinical stage biotech focused on the research and use of nucleotides, as therapeutics f...
Nyon, Switzerland
Novartis
Reimagining medicine by transforming cancer
Basel, Switzerland
Vivet Therapeutics
Vivet Therapeutics develops gene therapy treatments for inherited liver disorders using li...
Paris, France
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
South San Francisco, Unit...
About Vertex Pharmaceuticals
Vertex Pharmaceuticals, with its slogan The Science of Possibility, is a prominent entity in the biotechnology, health care, and pharmaceutical industries. Established in 1989, the company is headquartered in the United States and maintains a global presence through its research, development sites, and commercial offic...
Developing Innovative Medicines, Clinical Research and Trials, Patient Support and Education, Research and Development in Rare Diseases, Expanded Access Programs
Patients with Serious Diseases, Healthcare Providers, Research Scientists, STEM Students, Investors and Shareholders
Cystic Fibrosis, Sickle Cell Disease, Beta Thalassemia, Acute Pain, Neuropathic Pain, APOL1-mediated Kidney Disease, IgA Nephropathy, Autosomal Dominant Polycystic Kidney Disease, Type 1 Diabetes, Myotonic Dystrophy Type 1, Small Molecule Drugs, Inflammation, Autoimmune Diseases, Duchenne Muscular Dystrophy
B2B, B2C, B2D
Product Sales, Licensing, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Vertex Pharmaceuticals: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Vertex Pharmaceuticals on 9 Jun 2026. The 12 companies listed here were last checked between 4 Mar 2026 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
